|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1909944181 |
| 003 |
DE-627 |
| 005 |
20230514114209.0 |
| 007 |
tu |
| 008 |
130103s2013 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a sw121229_1
|
| 035 |
|
|
|a (DE-627)OLC1909944181
|
| 035 |
|
|
|a (DE-599)GBVOLC1909944181
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 570
|a 610
|
| 084 |
|
|
|a PHARM
|2 fid
|
| 084 |
|
|
|a XA 24552
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.43
|2 bkl
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 100 |
1 |
|
|a Patel, Kashyap
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Mechanism-Based Model of Parasite Growth and Dihydroartemisinin Pharmacodynamics in Murine Malaria
|
| 264 |
|
1 |
|c 2013
|
| 300 |
|
|
|a 9
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Batty, Kevin T.
|4 oth
|
| 700 |
1 |
|
|a Moore, Brioni R.
|4 oth
|
| 700 |
1 |
|
|a Gibbons, Peter L.
|4 oth
|
| 700 |
1 |
|
|a Bulitta, Jrgen B.
|4 oth
|
| 700 |
1 |
|
|a Kirkpatrick, Carl M.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Antimicrobial agents and chemotherapy
|d Washington, DC : American Society for Microbiology, 1962
|g 57(2013), 1 vom: Jan., Seite 508-516
|w (DE-627)129542318
|w (DE-600)217602-6
|w (DE-576)01499142X
|x 0066-4804
|7 nnns
|
| 773 |
1 |
8 |
|g volume:57
|g year:2013
|g number:1
|g month:01
|g pages:508-516
|g extent:9
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a FID-PHARM
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4112
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
r |
v |
|a XA 24552
|
| 936 |
b |
k |
|a 44.38
|q AVZ
|
| 936 |
b |
k |
|a 44.43
|q AVZ
|
| 936 |
b |
k |
|a 44.40
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 57
|j 2013
|e 1
|c 1
|h 508-516
|g 9
|
